Warby Parker Inc. (WRBY) is a publicly traded Healthcare sector company. As of November 5, 2026, WRBY trades at $25.37 with a market cap of $2.71B and a P/E ratio of 433.15. WRBY moved +19.16% today. Year to date, WRBY is -8.52%; over the trailing twelve months it is +8.23%. Its 52-week range spans $13.63 to $31.00. Analyst consensus is buy with an average price target of $30.22. Rallies surfaces WRBY's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Warby Parker narrows 2026 revenue guidance to $966 million–$976 million: Warby Parker reported third-quarter 2026 net revenue of $244.74 million, up 10% year over year, and net income of $5.6 million, down year over year. It narrowed full-year revenue guidance to $966 million–$976 million, representing 11%–12% growth versus 2025.
| Metric | Value |
|---|---|
| Price | $25.37 |
| Market Cap | $2.71B |
| P/E Ratio | 433.15 |
| EPS | $0.06 |
| Dividend Yield | 0.00% |
| 52-Week High | $31.00 |
| 52-Week Low | $13.63 |
| Volume | 53.74K |
| Avg Volume | 0 |
| Revenue (TTM) | $911.61M |
| Net Income | $7.74M |
| Gross Margin | 54.68% |
11 analysts cover WRBY: 0 strong buy, 8 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $30.22.